# Intermittent doxercalciferol (1α-Hydroxyvitamin D2) therapy for secondary hyperparathyroidism

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/intermittent-doxercalciferol-1-hydroxyvitamin-d2-therapy-for-secondary/

## Facts

| Field | Value |
| --- | --- |
| Author Names | João Frazão,Loganathan Elangovan,Hla M. Maung,Russell W. Chesney,Sergio R. Acchiardo,John D. Bower,Bobby J. Kelley,Hector J. Rodriguez,Keith C. Norris,John A. Robertson,Barton S. Levine,William G. Goodman,Dominick E. Gentile,Richard B. Mazess,Darlene M. Kyllo,Laura L. Douglass,Charles W. Bishop,Jack W. Coburn |
| Citations | 129 |
| DOI | 10.1053/ajkd.2000.16193 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2018567109 |
| PMID | 10977787 |
| Type | article |
| Year | 2000 |

## Paper authors

- [John D. Bower](https://scholariq.org/researchers/john-d-bower/)

## Paper journal

- [American Journal of Kidney Diseases](https://scholariq.org/journals/american-journal-of-kidney-diseases/)

## Paper primary topic

- [Parathyroid Disorders and Treatments](https://scholariq.org/topics/parathyroid-disorders-and-treatments/)

## Paper topics

- [Vitamin D Research Studies](https://scholariq.org/topics/vitamin-d-research-studies/)
- [Parathyroid Disorders and Treatments](https://scholariq.org/topics/parathyroid-disorders-and-treatments/)
- [Pharmacological Effects and Toxicity Studies](https://scholariq.org/topics/pharmacological-effects-and-toxicity-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.